Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis.

Journal of drugs in dermatology : JDD

Volumn 6, Issue 2, 2007, Pages 175-181

  Hebert, Adelaide A ^a   Cook Bolden, Fran E ^a   Basu, Sarmistha ^a   Calvarese, Barry ^a   Trancik, Ronald J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DESONIDE; STEROID;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOXICITY; FEMALE; HUMAN; HYDROGEL; INFANT; MALE; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DESONIDE; DOUBLE-BLIND METHOD; DRUG TOXICITY; FEMALE; HUMANS; HYDROGELS; INFANT; MALE; STEROIDS; TREATMENT OUTCOME;

EID: 34249659401     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)